UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2002-11, Vol.20 (21), p.4285-4291

2002

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3522-3530

1999

Volltextzugriff (PDF)

Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas

Anticancer research, 2011-04, Vol.31 (4), p.1315-1320

2011

Volltextzugriff (PDF)

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

Journal of clinical oncology, 1997-01, Vol.15 (1), p.297-303

1997

Volltextzugriff (PDF)

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

Oncology, 2012-01, Vol.83 (2), p.108-116

2012

Volltextzugriff (PDF)

Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen

Oncology, 2005-01, Vol.69 (5), p.391-398

2005

Volltextzugriff (PDF)

Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer

Journal of chemotherapy (Florence), 2008-06, Vol.20 (3), p.368-373

2008

Volltextzugriff (PDF)

Protective Effect of Leuprolide on Ovarian Function in Young Women Treated with Adjuvant Chemotherapy for Early Breast Cancer: A Multicenter Phase II Study

Journal of chemotherapy (Florence), 2008-12, Vol.20 (6), p.740-743

2008

Volltextzugriff (PDF)

Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer

Anticancer research, 2000-09, Vol.20 (5C), p.3675

2000

Volltextzugriff (PDF)

Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P6-P6-05-02

2016

Volltextzugriff (PDF)

Induction Chemotherapy to Weekly Paclitaxel Concurrent with Curative Radiotherapy in Stage IV (M0) Unresectable Head and Neck Squamous Cell Carcinoma: a Dose Escalation Study

Journal of chemotherapy (Florence), 2004-04, Vol.16 (2), p.201-205

2004

Volltextzugriff (PDF)

Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e11043-e11043

2011

Volltextzugriff (PDF)

Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e18110-e18110

2010

Volltextzugriff (PDF)

Preliminary Study of Pre-Metastatic Niche (PMN) in Nonmetastatic Nodes for the Assessment of Metastasis Risk in Breast Cancer (BC)

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.6024-6024

2009

Volltextzugriff (PDF)

Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21161-e21161

2011

Volltextzugriff (PDF)

Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e18063-e18063

2011

Volltextzugriff (PDF)

Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: Safety and activity results of our clinical experience

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e12005-e12005

2009

Volltextzugriff (PDF)

Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.15036-15036

2008

Volltextzugriff (PDF)

May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.19115-19115

2008

Volltextzugriff (PDF)

Efficacy of two oral dose regimens of granisetron

Anticancer research, 1995-09, Vol.15 (5B), p.2287

1995

Volltextzugriff (PDF)

Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e19085-e19085

2009

Volltextzugriff (PDF)

NEMESI: A retrospective observational longitudinal study to investigate italian early breast cancer (EBC) patient characteristics and treatment

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e11046-e11046

2010

Volltextzugriff (PDF)

Etoposide, l-Leucovorin and Fluorouracil (ELF) Regimen in Metastatic Gastric Cancer: A Phase II Study

Journal of chemotherapy (Florence), 1999-02, Vol.11 (1), p.74-77

1999

Volltextzugriff (PDF)

Hereditary breast/ovarian cancer families: The impact of mutation prediction models on BRCA1/2 mutation screening costs

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.20027-20027

2006

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(122)

Sprache

Englisch
(119)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Humans
(54)
Life Sciences & Biomedicine
(51)
Female
(38)
Biological And Medical Sciences
(34)
Male
(34)
Medical Sciences
(30)
Aged
(28)
Adult
(25)
Middle Aged
(24)
Oncology
(21)
Animals
(17)
Pharmacology. Drug Treatments
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(13)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(11)
Pharmacology & Pharmacy
(11)
Physical Sciences
(11)
Tumors
(11)
Chemotherapy
(10)
Aged, 80 And Over
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Prognostic impact of CD133 immunoexpression in node-negative invasive breast carcinomas

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study

The Role of Antiangiogenic Agents in the Treatment of Head and Neck Cancer

Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced or Metastatic Bladder Cancer: Long-Term Follow-Up of a 3-Week Regimen

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

Oral Vinorelbine as First Line Chemotherapy in Unfit Elderly Patients with Hormone-Refractory Prostate Cancer

Protective Effect of Leuprolide on Ovarian Function in Young Women Treated with Adjuvant Chemotherapy for Early Breast Cancer: A Multicenter Phase II Study

Gemcitabine as single agent in the treatment of elderly patients with advanced non small cell lung cancer

Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer

Induction Chemotherapy to Weekly Paclitaxel Concurrent with Curative Radiotherapy in Stage IV (M0) Unresectable Head and Neck Squamous Cell Carcinoma: a Dose Escalation Study

Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience

Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis

Preliminary Study of Pre-Metastatic Niche (PMN) in Nonmetastatic Nodes for the Assessment of Metastasis Risk in Breast Cancer (BC)

Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC)

Second-line therapy in advanced non-small cell lung cancer: Cytotoxic agents or tyrosine kinase inhibitors? Our experience

Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: Safety and activity results of our clinical experience

Role of MTHFR polymorphisms as predictive markers of acute toxicity during 5-fluorouracil based chemotherapy for colorectal cancer: Preliminary data

May the istotype influence the response to pemetrexed in patients with non small cell lung cancer? Preliminary data of our clinical experience

Efficacy of two oral dose regimens of granisetron

Activity and tolerability of cisplatin (CDDP) and fotemustine (FTM) in non-small cell lung cancer (NSCLC) patients (PTS) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia Meridionale (GOIM)

NEMESI: A retrospective observational longitudinal study to investigate italian early breast cancer (EBC) patient characteristics and treatment

Etoposide, l-Leucovorin and Fluorouracil (ELF) Regimen in Metastatic Gastric Cancer: A Phase II Study

Hereditary breast/ovarian cancer families: The impact of mutation prediction models on BRCA1/2 mutation screening costs

Aktive Filter

Suchergebnisse filtern